About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Georgia | 41 Studies

Clinical Trials DiabetesGeorgia

Diabetes Clinical Trials in Georgia

Find 41 clinical trials for diabetes near Georgia. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 41 trials

RecruitingModeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of GlucotoxicityThe goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a…NCT06699810·Atlanta, Georgia and 1 other CompletedAutomated Insulin Delivery for Inpatients With DysglycemiaThis randomized controlled trial will test the efficacy and safety of automated insulin delivery (AID) in hospitalized patients with diabetes (type 1 or type 2) requiring insulin…NCT06418880·Stanford, California and 2 others RecruitingDiabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-managementThe goal of this clinical trial is to evaluate whether an audio diary mobile application (Fabla-diabetesMM) is feasible to use and may support self-management in older adults with…NCT07474376·Atlanta, Georgia TerminatedInhaled Technosphere Insulin in Subjects With Diabetes Mellitus and AsthmaThe clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes…NCT00332826·Phoenix, Arizona and 77 others

PreviousPage 2 of 3Next

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEffectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsThe purpose of the study is to evaluate the safety and effectiveness of the Abbott Sensor Based Glucose Monitoring System Personal (System-P) and Abbott Sensor Based Glucose…NCT02283411·Santa Barbara, California and 5 others

WithdrawnSYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesThe purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes.NCT06719531·Birmingham, Alabama and 27 others

CompletedFeasibility Study of New Subcutaneous Glucose Sensor With Recording DevicesThe purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with…NCT04020822·Aurora, Colorado and 1 other

UnknownEffectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusThe purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with diabetes mellitus.NCT04838392·Guntersville, Alabama and 12 others

CompletedRemote Monitoring in Diabetes Disease ManagementThe primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard…NCT00675311·Marietta, Georgia

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

RecruitingEvaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 DiabetesThis study will collect sensor data in subjects with T1D or T2D, 2-80 years of age.NCT07864168·Chula Vista, California and 17 others

CompletedComparison of Glycemic Control Among Diabetics Using Three Different Pen NeedlesAnxiety about needles is a commonly expressed concern by diabetics about beginning insulin therapy.NCT00928057·Birmingham, Alabama and 3 others

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

CompletedEvaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring SystemThe purpose of this study is to demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against Reader capillary Blood…NCT02073058·Escondido, California and 3 others

CompletedKetosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin TreatmentThe study intends on enrolling 48 subjects with diabetes.NCT01099618·Atlanta, Georgia

TerminatedEfficacy of Aliskiren in the Treatment of Diabetic Macular EdemaTo assess the efficacy of oral aliskiren as a therapy for diabetic macular edemaNCT00768040·Phoenix, Arizona and 11 others

CompletedEfficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsThis trial is conducted in the United States of America (USA).NCT00773279·Burlingame, California and 64 others

CompletedAdult Accuracy Study of the Enlite 3 Glucose SensorThe purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and…NCT02246582·Escondido, California and 5 others

CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

Other Conditions in Georgia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia